A study on AD demonstrated that the E3 ubiquitin ligase COP1 inhibits the activation of microglia and the release of pro-inflammatory factors by degrading the transcription factor CCAAT/enhancer binding protein beta (c/EBPβ) (Ndoja et al., 2020). This evidence concerns the gene CEBPB and Alzheimer disease.